Grace Therapeutics (GRCE) Non Operating Income (2016 - 2026)
Grace Therapeutics' Non Operating Income was $153,000 in fiscal Q2 2027 (quarter ended Sep 30, 2026), down 90.4% from $1.59 million a year earlier but up 20.5% from the prior quarter.
Grace Therapeutics (GRCE) Non Operating Income (2016 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Non Operating Income was $546,000 through Sep 30, 2026, down 82.2% year-over-year; for FY2026 (ended Mar 31, 2026), it was $1.58 million, down 59.5% from FY2025.
- In earlier fiscal years, Non Operating Income was $3.91 million in FY2025, -$1.83 million in FY2024, $184,000 in FY2023 (-96.4%) and $5.12 million in FY2022.
- Quarterly Non Operating Income has moved between -$1.63 million (fiscal Q2 2024) and $2.8 million (fiscal Q4 2025) over five years.
- Per Business Quant data, GRCE's Non Operating Income in the three fiscal quarters before Q2 2027 was $127,000 (Q1 2027), $132,000 (Q4 2026) and $134,000 (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | - |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | - |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | - |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | - |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 153,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 153,000.00 |
| Jun 30, 2026 | 127,000.00 |
| Mar 31, 2026 | 132,000.00 |
| Dec 31, 2025 | 134,000.00 |
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | -272,000.00 |
| Mar 31, 2025 | 2.80 Mn |
| Dec 31, 2024 | -1.06 Mn |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | 1.62 Mn |
| Mar 31, 2024 | -792,000.00 |
| Dec 31, 2023 | 444,000.00 |
| Sep 30, 2023 | -1.63 Mn |
| Jun 30, 2023 | 142,000.00 |
| Mar 31, 2023 | 115,000.00 |
| Dec 31, 2022 | 82,000.00 |
| Sep 30, 2022 | 24,000.00 |
| Jun 30, 2022 | -36,000.00 |
| Mar 31, 2022 | -149,000.00 |
| Dec 31, 2021 | 696,000.00 |
Grace Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();